Insider Trading & Ownership of Philip S. Low

Location: West Lafayette, IN
Summary: The estimated net worth of Philip S. Low is at least $488,126 dollars as of 23 May 2022. Philip S. Low is the Director of Cortexyme, Inc. and owns shares of Quince Therapeutics, Inc. (QNCX) stock worth about $488.1K.
Signature: /s/ Chris Lowe, Attorney-in-Fact for Philip S. Low
All Insider Reports: All Insider Reports

Notify me when Philip S. Low files a new Insider Trading report.

Ownership of Philip S. Low

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
QNCX	Quince Therapeutics, Inc.	Director	$488,126			19 May 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.